NAICS 541714 · federal spend
Who buys Research & Development in Biotechnology… for the federal government?
Federal agencies obligated $3.9B on Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714) in prime contracts in FY2024 — the #33 most-contracted federal NAICS. Below are the states where it's a leading category; open any state for its full picture.
$3.9BFederal spend · NAICS 541714 (FY2024)
#33Most-contracted federal NAICS
16States where it's a leading category
States where Research & Development in Biotechnology… is a leading federal category
These states rank NAICS 541714 among their largest federal contracting categories (FY2024, place of performance). Open a state for its full picture.
01$1,823,448,419
South Carolina
02$347,071,517
North Carolina
03$303,005,678
California
04$269,548,417
Massachusetts
05$260,266,921
Alabama
06$182,205,271
Maryland
07$112,786,506
Oregon
08$78,733,055
Utah
09$36,093,712
Ohio
10$33,812,380
New Jersey
11$29,096,767
Washington
12$18,552,328
New Mexico
13$10,691,380
Delaware
14$10,580,914
Hawaii
15$5,208,239
Arkansas
16$3,018,848
Maine
Source: USAspending.gov — federal prime-contract awarding-agency obligations, FY2024 (public record). Figures are historical award totals shown for buyer research, not a forecast, guarantee, or solicitation. Verify current opportunities and eligibility at SAM.gov and the issuing agency.
P4 One capability statement →